RELATION OF ANTIPLATELET THERAPY DISCONTINUATION AFTER CORONARY STENTING WITH THE RISK OF ADVERSE CARDIOVASCULAR EVENTS

被引：0
作者：
Watanabe, Hirotoshi [1 ]
Morimoto, Takeshi [1 ]
Kimura, Takeshi [1 ]
机构：
[1] Kyoto Univ, Grad Sch Med, Dept Cardiovasc Med, Kyoto, Japan
来源：
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY | 2014年 / 63卷 / 12期
关键词：
D O I：
10.1016/S0735-1097(14)61533-3
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
915-06
引用
收藏
页码：A1530 / A1530
页数：1
相关论文
共 50 条
  • [21] Discontinuation of hormone replacement therapy after myocardial infarction and short term risk of adverse cardiovascular events: nationwide cohort study
    Bretler, Ditte-Marie
    Hansen, Peter Riis
    Sorensen, Rikke
    Lindhardsen, Jesper
    Ahlehoff, Ole
    Andersson, Charlotte
    Abildstrom, Steen Zabell
    Torp-Pedersen, Christian
    Gislason, Gunnar Hilmar
    BMJ-BRITISH MEDICAL JOURNAL, 2012, 344
  • [22] Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting
    Palmerini, Tullio
    Reggiani, Letizia Bacchi
    Della Riva, Diego
    Romanello, Mattia
    Feres, Fausto
    Abizaid, Alexandre
    Gilard, Martine
    Morice, Marie-Claude
    Valgimigli, Marco
    Hong, Myeong-Ki
    Kim, Byeong-Keuk
    Jang, Yangsoo
    Kim, Hyo-Soo
    Park, Kyung Woo
    Colombo, Antonio
    Chieffo, Alaide
    Ahn, Jung-Min
    Park, Seung-Jung
    Schuepke, Stefanie
    Kastrati, Adnan
    Montalescot, Gilles
    Steg, Philippe Gabriel
    Diallo, Abdourahmane
    Vicaut, Eric
    Helft, Gerard
    Biondi-Zoccai, Giuseppe
    Xu, Bo
    Han, Yaling
    Genereux, Philippe
    Bhatt, Deepak L.
    Stone, Gregg W.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (16) : 2011 - 2022
  • [23] Very late coronary stent thrombosis after discontinuation of antiplatelet therapy
    Cardona, Lorette
    Simas, Angela
    Lousinha, Ana
    Fiarresga, Antonio
    de Sousa, Lidia
    Cacela, Duarte
    Patricio, Lino
    Bernardes, Luis
    Ferreira, Rui
    REVISTA PORTUGUESA DE CARDIOLOGIA, 2011, 30 (03) : 333 - 339
  • [24] Antiplatelet is superior to anticoagulant treatment after coronary stenting: Fewer coronary and other events within 30 days after stenting
    Foussas, S
    Alexopoulos, D
    Stefanadis, C
    Olympios, C
    Voudris, V
    Hatzimiltiadis, S
    Sionis, D
    Vavouranakis, E
    Vrahatis, A
    Fakiolas, C
    Pissimisis, E
    Stefanidis, A
    Zairis, M
    Pavlides, G
    Vitakis, S
    Louridas, G
    Cokkinos, D
    Toutouzas, P
    ANGIOLOGY, 2000, 51 (04) : 289 - 294
  • [25] Discontinuation of Dual Antiplatelet Therapy Over 12 Months after Acute Coronary Syndromes Increases Risk for Adverse Events in Patients Treated with Percutaneous Coronary Intervention: Systematic Review and Meta-Analysis
    D'Ascenzo, Fabrizio
    Colombo, Francesco
    Barbero, Umberto
    Moretti, Claudio
    Omede, Pierluigi
    Reed, Matthew J.
    Tarantini, Giuseppe
    Frati, Giacomo
    Di Nicolantonio, James J.
    Zoccai, Giuseppe Biondi
    Gaita, Fiorenzo
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2014, 27 (03) : 233 - 241
  • [26] Net Adverse Clinical Events With Antiplatelet Therapy in Acute Coronary Syndromes
    Bates, Eric R.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 324 (16): : 1613 - 1615
  • [27] Combining warfarin and antiplatelet therapy after coronary stenting in the Global Registry of Acute Coronary Events: is it safe and effective to use just one antiplatelet agent?
    Nguyen, Michael C.
    Lim, Yean L.
    Walton, Antony
    Lefkovits, Jeffrey
    Agnelli, Giancarlo
    Goodman, Shaun G.
    Budaj, Andrzej
    Gulba, Dietrich C.
    Allegrone, Jeanna
    Brieger, David
    EUROPEAN HEART JOURNAL, 2007, 28 (14) : 1717 - 1722
  • [28] Combining warfarin and antiplatelet therapy after coronary stenting in the global registry of acute coronary events: Is it safe and effective to use just one antiplatelet agent?
    Nguyen, M
    Lim, YL
    Walton, A
    Lefkovits, J
    Agnelli, G
    Goodman, SG
    Budaj, A
    Gull, DC
    Allegrone, J
    Brieger, D
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2006, 47 (04) : 252A - 252A
  • [29] Discontinuation of dual antiplatelet therapy over 12 months after acute coronary syndromes increases risk for adverse events in patients treated with pci: systematic review and meta-analysis
    Colombo, F.
    D'ascenzo, F.
    Moretti, C.
    Omede, P.
    Fox, K. A. A.
    Rumsfeld, J. S.
    Tarantini, G.
    Biondi-Zoccai, G.
    Gaita, F.
    EUROPEAN HEART JOURNAL, 2014, 35 : 25 - 26
  • [30] Dual Antiplatelet Drug Resistance Is a Risk Factor for Cardiovascular Events after Percutaneous Coronary Intervention
    Ivandic, Boris T.
    Sausemuth, Mareike
    Ibrahim, Hesham
    Giannitsis, Evangelos
    Gawaz, Meinrad
    Katus, Hugo A.
    CLINICAL CHEMISTRY, 2009, 55 (06) : 1171 - 1176
12345